GLP-1 and the Gut Microbiome: A Bidirectional Story The relevance of probiotics during GLP-1 use is grounded in real biology that goes beyond just "gut health." A 2026 narrative review in the British Journal of Clinical Pharmacology examined the bidirectional relationship between GLP-1 RAs and the gut microbiome.[4] The review documents that: GLP-1 RAs themselves modify gut microbial composition, with several studies showing shifts in the Firmicutes/Bacteroidetes ratio and increased abundance of certain Bifidobacterium and Lactobacillus species during treatment The gut microbiome in turn produces metabolites (short-chain fatty acids, secondary bile acids) that stimulate endogenous GLP-1 secretion Microbiome composition may influence inter-individual response to GLP-1 therapy through inflammation, insulin sensitivity, and metabolic pathways The implication for probiotic supplementation: the period during GLP-1 use is one of meaningful microbial change driven by altered transit, reduced food intake, and direct drug effects

In a 2019 study, consuming 500 mg of amla extract twice daily for 12 weeks reduced triglyceride, total cholesterol, and LDL (bad) cholesterol levels in 98 people with abnormal blood lipid levels
Many of our Summerlin patients drive from Henderson, North Las Vegas, and surrounding areas
Inspire Medical Systems (INSP), AdaptHealth (AHCO) & Quipt Home Medical (QIPT) all, additionally, face challenges
Patients and prescribers should exercise caution and seek professional advice, considering the individual's health profile, potential drug interactions, and pre-existing conditions
Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: a systematic review and meta-analysis[J]